Determining the risk factors for xerostomia in dental out-patients

Cover Page


Cite item

Abstract

Aim. To determine the risk factors for xerostomia.

Methods. The study included 137 patients aged 25 to 60 years (61 males, 76 females), the main group consisted of 40 patients with xerostomia (11 males, 29 females), with a median age of 44.5 years (38; 49.5). The control group included 97 patients without xerostomia (50 males, 47 females), median age - 42 years (36; 49). The questionnaire by V.V. Afanas’ev (1993) was used to collect the complaints, anamnesis and to determine the risk factors for xerostomia. Qualitative indicators are listed as absolute numbers and shares (%). In assessing the statistical significance of qualitative indicators differences, contingency tables with subsequent Pearson chi-square test were used.

Results. Among the patients of the main group, 19 (47.5%) took medications decreasing the salivation, with intake period duration ranging from 1 to 4 months. When questioned, patients with xerostomia reported statistically significant increase in the rates of cardiovascular disorders (15 patients, 37.5%), gastrointestinal tract diseases (11 patients, 27.5%), endocrine diseases (10 patients, 25%), musculoskeletal diseases (9 patients, 22.5%). The combination of three or more positive answers on V.V. Afanas’ev questionnaire questions was revealed in 12 (30%) patients of the main group, which was significantly higher compared to the control group (1 patient, 1.03%).

Conclusion. The most typical reasons for developing xerostomia were the following: taking medications decreasing the salivation, presence of cardiovascular, gastrointestinal, musculoskeletal and endocrine disorders. Three or more positive answers on V.V. Afanas’ev questionnaire questions increase the probability of detecting xerostomia in a respondent.

About the authors

K V Komarova

Novokuznetsk State Institute of Postgraduate Medicine, Novokuznetsk, Russia

Author for correspondence.
Email: komarovakv@yandex.ru

N N Ratkina

Novokuznetsk State Institute of Postgraduate Medicine, Novokuznetsk, Russia

Email: komarovakv@yandex.ru

V K Polenichkin

Novokuznetsk State Institute of Postgraduate Medicine, Novokuznetsk, Russia

Email: komarovakv@yandex.ru

E P Karmanov

Novokuznetsk State Institute of Postgraduate Medicine, Novokuznetsk, Russia

Email: komarovakv@yandex.ru

References

  1. Афанасьев В.В. Слюнные железы. Болезни и травмы. - М.: ГЭОТАР-Медиа, 2012. - 296 с.
  2. Вавилова Т.Н., Янушевич О.О., Островская И.Г. Слюна. Аналитические возможности и перспективы. - М.: БИНОМ, 2014. - 312 с. .
  3. Вейсгейм Л.Д., Гаврикова Л.М., Дубачёва С.Г. Применение средств гигиены полости рта Mexidol Dent для профилактики заболеваний слизистой оболочки полости рта у больных с ксеростомией // Стоматология. - 2014. - Т. 93, №3. - С. 15-17.
  4. Денисов А.Б. Слюна и слюнные железы. - М.: Издательство РАМН, 2009. - 472 с.
  5. Деркачева Е.И., Ронь Г.И. Клинические проявления в полости рта при ксеростомии // Урал. мед. ж. - 2014. - №5 (119). - С. 44-47.
  6. Комарова К.В., Раткина Н.Н., Поленичкин В.К. Способ оценки секреторной функции слюнных желёз // Казанский мед. ж. - 2013. - Т. 94, №2. - С. 245-246.
  7. Макеева И.М., Дорошина В.Ю., Аракелян М.Г. Ксеростомия и средства, облегчающие её проявление // Стоматология. - 2013. - Т. 92, №5. - С. 12-13.
  8. Панин А.М. Хирургическая стоматология. Воспалительные и дистрофические заболевания слюнных желёз. - М.: Литтерра, 2011. - 208 с.
  9. Villa A., Abati S. Risk factors and symptoms associated with xerostomia: a cross-sectional study // Austr. Dent. J. - 2011. - Vol. 56. - P. 290-295. http://dx.doi.org/10.1111/j.1834-7819.2011.01347.x
  10. Villa A., Polimeni A., Strohmenger L. et al. Dental patients’ self-reports of xerostomia and associated risk factors // J. Am. Dent. Assoc. - 2011. - Vol. 142, N 7. - P. 811-816. http://dx.doi.org/10.14219/jada.archive.2011.0269

© 2015 Komarova K.V., Ratkina N.N., Polenichkin V.K., Karmanov E.P.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies